• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Resources
    • Resources Overview
    • Elevated Insights
    • Presentations & Publications
    • Whitepapers
  • Media
    • Media Overview
    • Press Releases
    • Featured News
  • Facilities
  • Careers
  • Contact
  • Search
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact
  • Manufacturing & Discovery Services

    Manufacturing & Discovery Services Overview

    Capabilities & Services
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    Expertise
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
    • Investors

Presentations & Publications

// Oct 06, 2025 | Presentation

2025 Cell & Gene Meeting on the Mesa

ElevateBio BaseCamp – Delivering Genetic Medicines From Concept Through Commercialization

View Presentation

// Oct 06, 2025 | Presentation

2025 Cell & Gene Meeting on the Mesa

ElevateBio Life Edit – Opening New Frontiers in Genomic Medicine

View Presentation

// Sep 24, 2025 | Presentation

CAR-TCR Summit

Successfully Implementing Lean Manufacturing for Late Phase and Commercial CGT

View Presentation

// Sep 24, 2025 | Presentation

CAR-TCR Summit

Non-Viral TCR Knock-In Using LEG14 Nuclease and HDR Templates for T-Cell Engineering

View Presentation

// Sep 16, 2025 | Poster

BioProcess International Conference

Streamlining CRISPR-Cas9 gene editing with LipidBrick® Cell Ready

View Poster

// Jul 22, 2025 | Presentation

5th mRNA-Based Therapeutics Summit 2025

In Vivo Investigation of RNA Optimization Strategies for Maximizing Gene Editing in the Liver

View Presentation

// Jun 12, 2025 | Presentation

CASSS CGTP Summit Rockville, MD

Optimizing Analytical Release Testing Through Reduced Volume and Turnaround Times

View Presentation

// Jun 11, 2025 | Presentation

CASSS CGTP Summit Rockville, MD

Advanced Sequencing Approaches for Comprehensive AAV Vector Characterization

View Presentation

// Jun 02, 2025 | Presentation

Cell & Gene Therapy Talk Framingham, MA

A Novel Approach to Treating Huntington’s Disease Using AAV to Deliver Gene Editing Tools to the Brain

View Presentation

// May 17, 2025 | Presentation

American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Advancing Lentiviral Vector Manufacturing: A Platform for Commercial Cell Therapy Success

View Presentation

// May 17, 2025 | Presentation

American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Broad Biodistribution and Expression of Allele Selective LETI-101 in Critical Brain Regions for Treatment of Huntington’s Disease Following Intrastriatal Delivery in NHP

View Presentation

// May 15, 2025 | Poster

American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Deep CRISPR Nuclease Portfolio and Multiple Editing Modalities Accelerates Identification of Viable Clinical Candidates

View Poster

  • Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 7
  • Next

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2026 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • Manufacturing & Discovery Services
  • Technologies
  • Advanced Therapies
  • Partner With Us
  • About
  • Presentations & Publications
  • Elevated Insights
  • Careers
  • Facilities
  • Contact
MENU
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact